|
|
|
| 
|
|
|
My Recent Searches
|
|
|
|
|
|
|
|
|
Mineralys Therapeutics, Inc. (MLYS) |
|
|
$0.00 0.00 (0.00%) as of 4:30 Tue 11/30
|
|
Download |
|
|
| |
| |
| Exchange: |
N/A |
| Security
Type: |
Common |
| Shares
Out: |
40,860,000 |
| Market
Cap: |
N/A |
| Last
Volume: |
0 |
Avg
Vol: |
0 |
| 52
Week Range: |
$0 - $0 |
|
| Level
I Sector: |
N/A |
| Level
II Sector: |
N/A |
| Level
III Sector: |
N/A |
|
Member Indexes:
|
Rankings:
|
|
| Insider 3 Months : - |
| Insider 6 Months : - |
| Insider 3/6 Months : - |
|
| Guru Rank Number : - |
| Guru Rank Value : - |
| Guru Occurances : - |
|
|
|
|
|
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
|
3m +/-:
|
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
|
Actions:
|
|
|
| B |
Buy |
| S |
Sell |
| OE |
Option
Exercised |
| A |
Acquired |
| D |
Disposed |
| AB |
Automatic
Buy |
| AS |
Automatic
Sell |
| IO |
Initial
Ownership |
|
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
| |
| |
Summary (Direct Transactions Only)  |
3 Months |
6 Months |
12 Months |
24 Months |
| Total Shares Bought |
0 |
555,555 |
566,305 |
3,322,555 |
| Total Buy Value |
$0 |
$7,499,993 |
$7,605,534 |
$51,705,534 |
| Total People Bought |
0 |
1 |
2 |
6 |
| Total Buy Transactions |
0 |
1 |
5 |
10 |
| Total Shares Sold |
246,053 |
246,053 |
477,769 |
477,769 |
| Total Sell Value |
$3,129,788 |
$3,129,788 |
$6,124,189 |
$6,124,189 |
| Total People Sold |
3 |
3 |
3 |
3 |
| Total Sell Transactions |
11 |
11 |
13 |
13 |
| End Date |
2024-04-28 |
2024-01-26 |
2023-07-28 |
2022-07-28 |
|
| Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
  Rodman David Malcom |
Chief Medical Officer |
• – – |
2024-07-16 |
4 |
AS |
$15.00 |
$7,876 |
D/D |
(525) |
102,873 |
|
- |
|
| Rodman David Malcom |
Chief Medical Officer |
• – – |
2024-07-16 |
4 |
OE |
$1.08 |
$567 |
D/D |
525 |
103,398 |
|
- |
|
| Rodman David Malcom |
Chief Medical Officer |
• – – |
2024-07-12 |
4 |
OE |
$1.08 |
$6,857 |
D/D |
6,349 |
102,873 |
|
- |
|
| Congleton Jon |
Chief Executive Officer |
• • – |
2024-07-11 |
4 |
AS |
$13.34 |
$210,075 |
D/D |
(15,746) |
911,212 |
|
- |
|
| Rodman David Malcom |
Chief Medical Officer |
• – – |
2024-07-11 |
4 |
OE |
$0.54 |
$2,709 |
D/D |
5,017 |
96,524 |
|
- |
|
| Levy Adam Scott |
CFO and Secretary |
• – – |
2024-07-11 |
4 |
AS |
$13.14 |
$141,394 |
D/D |
(10,757) |
247,611 |
|
- |
|
| Congleton Jon |
Chief Executive Officer |
• • – |
2024-06-20 |
4 |
AS |
$11.73 |
$175,237 |
D/D |
(14,940) |
926,958 |
|
- |
|
| Congleton Jon |
Chief Executive Officer |
• • – |
2024-06-18 |
4 |
AS |
$11.99 |
$199,073 |
D/D |
(16,607) |
941,898 |
|
- |
|
| Congleton Jon |
Chief Executive Officer |
• • – |
2024-06-17 |
4 |
AS |
$12.25 |
$217,712 |
D/D |
(17,766) |
958,505 |
|
- |
|
| Congleton Jon |
Chief Executive Officer |
• • – |
2024-06-14 |
4 |
AS |
$12.52 |
$203,163 |
D/D |
(16,229) |
976,271 |
|
- |
|
| Congleton Jon |
Chief Executive Officer |
• • – |
2024-06-13 |
4 |
AS |
$12.74 |
$509,027 |
D/D |
(39,961) |
992,500 |
|
- |
|
| Congleton Jon |
Chief Executive Officer |
• • – |
2024-06-12 |
4 |
AS |
$12.77 |
$212,013 |
D/D |
(16,607) |
1,032,461 |
|
- |
|
| Rodman David Malcom |
Chief Medical Officer |
• – – |
2024-06-12 |
4 |
OE |
$1.08 |
$6,857 |
D/D |
6,349 |
89,729 |
|
- |
|
| Rodman David Malcom |
Chief Medical Officer |
• – – |
2024-06-11 |
4 |
OE |
$0.54 |
$2,709 |
D/D |
5,017 |
83,380 |
|
- |
|
| Levy Adam Scott |
CFO and Secretary |
• – – |
2024-06-11 |
4 |
AS |
$12.94 |
$1,252,718 |
D/D |
(96,815) |
255,462 |
|
- |
|
| Rodman David Malcom |
Chief Medical Officer |
• – – |
2024-05-13 |
4 |
OE |
$0.54 |
$9,566 |
D/D |
11,366 |
78,363 |
|
- |
|
| Rodman David Malcom |
Chief Medical Officer |
• – – |
2024-05-09 |
4 |
AS |
$15.00 |
$1,500 |
D/D |
(100) |
66,997 |
|
- |
|
| Rodman David Malcom |
Chief Medical Officer |
• – – |
2024-05-09 |
4 |
OE |
$1.08 |
$108 |
D/D |
100 |
67,097 |
|
- |
|
| Rodman David Malcom |
Chief Medical Officer |
• – – |
2024-04-12 |
4 |
OE |
$1.08 |
$6,857 |
D/D |
6,349 |
66,997 |
|
- |
|
| Rodman David Malcom |
Chief Medical Officer |
• – – |
2024-04-11 |
4 |
OE |
$0.54 |
$2,709 |
D/D |
5,017 |
60,648 |
|
- |
|
| Rodman David Malcom |
Chief Medical Officer |
• – – |
2024-03-12 |
4 |
OE |
$1.08 |
$6,856 |
D/D |
6,348 |
55,631 |
|
- |
|
| Rodman David Malcom |
Chief Medical Officer |
• – – |
2024-03-11 |
4 |
OE |
$0.54 |
$2,709 |
D/D |
5,017 |
49,283 |
|
- |
|
| Shah Rajeev M. |
Director |
– • – |
2024-02-12 |
4 |
A |
$13.50 |
$22,578,858 |
I/I |
1,672,508 |
2,983,755 |
|
- |
|
| Akkaraju Srinivas |
|
– • • |
2024-02-12 |
4 |
A |
$13.50 |
$7,499,993 |
I/I |
555,555 |
5,074,916 |
|
- |
|
| Samsara Biocapital, L.p. |
10% Owner |
– – • |
2024-02-12 |
4 |
B |
$13.50 |
$7,499,993 |
I/I |
555,555 |
5,074,916 |
1.5 |
- |
|
51 Records found
|
|
Page 1 of 3 |
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
| |
OE |
- Options Exercised |
A |
- Acquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
